Noticias de PFE_US

Noticias del mercado

Últimas noticias sobre PFE_US — 281 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: PFE_US ✕ 281 resultados
08/04/2026 PFE_US — MarketWatch
Pfizer Inc. stock rises Wednesday, still underperforms market
07/04/2026 PFE_US — MarketWatch
Pfizer Inc. stock underperforms Tuesday when compared to competitors
06/04/2026 PFE_US — Pfizer ES ← EN
Cómo la IA ya está remodelando la atención del cáncer
06/04/2026 PFE_US — MarketWatch
Pfizer Inc. stock underperforms Monday when compared to competitors
03/04/2026 PFE_US — sonla.gov.vn ES ← EN
Análisis de acciones de PFE: Pfizer Inc. Pharma cae un 0,81% a 28,32 dólares evaluando el soporte a corto plazo
03/04/2026 PFE_US — haiphong.gov.vn
PFE Stock Analysis: Pfizer Inc. Pharma Falls 0.81% to $28.32 Assessing Near Term Support
03/04/2026 PFE_US — tayninh.gov.vn
PFE Stock Analysis: Pfizer Inc. Pharma Falls 0.81% to $28.32 Assessing Near Term Support
01/04/2026 PFE_US — Investopedia
Top Pfizer Shareholders
31/03/2026 PFE_US — MarketWatch
Pfizer Inc. stock rises Tuesday, still underperforms market
30/03/2026 PFE_US — Yahoo Finance
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
30/03/2026 PFE_US — Stock Titan
Pfizer (PFE) director Echevarria granted 1,710 Phantom Stock Units as deferred pay
30/03/2026 PFE_US — Stock Titan
Pfizer (NYSE: PFE) director awarded new phantom stock units
30/03/2026 PFE_US — Stock Titan
Pfizer (NYSE: PFE) director receives deferred phantom stock award
26/03/2026 PFE_US — The Acquirer's Multiple
Pfizer Inc (PFE): Our Calculation of Intrinsic Value
25/03/2026 PFE_US — Yahoo Finance
Pfizer Inc. (PFE) Announces Positive Topline Results From Phase 3 TALAPRO-3 Study of TALZENNA®
23/03/2026 PFE_US — Contagion Live
Pfizer and Valneva Report Vaccine Efficacy Data for Their Lyme Disease Candidate
23/03/2026 PFE_US — Business Wire
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
23/03/2026 PFE_US — Reuters
Pfizer-Valneva Lyme vaccine shows more than 70% efficacy but misses key goal
23/03/2026 PFE_US — The Detroit News
Pfizer says long-awaited Lyme vaccine was effective in study
20/03/2026 PFE_US — Business Wire ES ← EN
Pfizer recomienda a los accionistas rechazar la minioferta de Tutanota LLC

Página 13 de 15

keyboard_arrow_up